- Practical management of drug-induced long QT syndrome
- Genotype-Specific Electrophysiological Remodeling in PLN R14del Cardiomyopathy: Implications for Precision Antiarrhythmic Therapy
- Ca2+ current involvement in a KCNH2 mutation's phenotype and its modulation by estrogen
- Ca2+ current involvement in a KCNH2 mutation's phenotype and its modulation by estrogen
- Atrial Flutter-Triggered Ventricular Tachycardia Storm in Gitelman Syndrome: A Case Report
- An Unusual Genetic Variant of Long QT Syndrome with Late Presentation in the Sixth Decade
- How to Replace the TQT Study-The Use of Concentration-QTc Modeling to Exclude a Small Effect of a Novel Drug on QT Interval: Historical Perspective and Implementation
- Circadian Pattern of Ventricular Fibrillation-Terminating Shocks among Patients with Diagnosed and Treated Congenital Long QT Syndrome
- Assessing the risk of drug-induced corrected QT interval prolongation in primary care
- Combined Leadless Pacing and Subcutaneous ICD Therapy in Long QT Syndromes
- Prominent T-wave induced by Valsalva maneuver associated with a RYR2 loss-of-function variant
- Jervell and Lange-Nielsen Syndrome Related Clinical Genetics and Experimental Models
- hERG1 channels and potential therapeutics for long QT syndrome
- Polymorphic ventricular tachycardia with mutation in KCNJ2: case report
- Electrocardiographic Repolarization Changes Following Orchiectomy: Insights Into QT Interval Prolongation and Clinical Implications
- Case Report: Nadolol-mexiletine combination therapy for refractory neonatal long QT syndrome: a case series beyond sodium channelopathies
- Multisystemic Assessment in Andersen-Tawil Syndrome: Report of Eighteen Individuals
- Rare pathogenic mutation of KCNH2 p.D501N associated with early-onset malignant long QT syndrome
- Off-Target Inhibition of PKA RII by Crizotinib Leads to Reduced hERG Expression and Acquired QT Prolongation
- Increased Arrhythmic Risk in Obesity Is Transduced by Adipose Tissue-Derived Extracellular Vesicles
- Spectrum of potentially lethal cardiac conditions presenting with fetal sinus bradycardia: a report on 34 cases
- Risk Stratification of Patients With Type 2 Long-QT Syndrome Through Analysis of T-Wave Morphology
- Sudden death across brain and heart: cardio-cerebral ion channel dysfunction as a potential risk-modifying mechanism linking epilepsy and long QT syndrome
- Thorough QT/QTc Clinical Study to Evaluate the Effect of Remdesivir on Cardiac Repolarization in Healthy Participants
- Cardiac arrest due to acquired long QT syndrome during gynecologic laparoscopy: a case report
- Selective Use of Nonselective Beta-Blockers: A Tailored Antiarrhythmic Approach
- Perinatal management of congenital long QT syndrome: A case of maternal and fetal manifestations
- C-terminal long-QT type 1 R562S-Kv7.1 variant, the first variant in helix C impairing beta-adrenergic response of the slow delayed rectifier K+ channel
- Comparative Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Real-World Cohort Study
- Sudden cardiac arrest in young adults: A comprehensive systematic review of epidemiology, aetiology and preventive strategies
- Evaluating the impact of SDHAF3 p.F53L genetic variant on clinically significant QTc prolongation in patients prescribed high-risk medications: a retrospective pharmacogenetic study
- Optimization of novel compounds using computer-aided drug design for treatment of cardiac arrhythmia
- A hERG Blocker Facilitates K + Channel Current by Agonizing Pore Opening while Blocking
- A hERG Blocker Facilitates K + Channel Current by Agonizing Pore Opening while Blocking
- A hERG Blocker Facilitates K+ Channel Current by Agonizing Pore Opening while Blocking
- A hERG Blocker Facilitates K + Channel Current by Agonizing Pore Opening while Blocking
- A hERG Blocker Facilitates K + Channel Current by Agonizing Pore Opening while Blocking
- A hERG Blocker Facilitates K+ Channel Current by Agonizing Pore Opening while Blocking
- A hERG Blocker Facilitates K + Channel Current by Agonizing Pore Opening while Blocking
- A hERG Blocker Facilitates K+ Channel Current by Agonizing Pore Opening while Blocking
- A hERG Blocker Facilitates K+ Channel Current by Agonizing Pore Opening while Blocking
- Motif-Level Graph Learning Enables Interpretable Prediction of Drug-Induced QT Prolongation via Cooperative Substructural Determinants
- SafeBeat Rx-Moving ECG AI Beyond Diagnostics to Recommending Treatment
- A hERG Blocker Facilitates K + Channel Current by Agonizing Pore Opening while Blocking
- A hERG Blocker Facilitates K+ Channel Current by Agonizing Pore Opening while Blocking
- A hERG Blocker Facilitates K + Channel Current by Agonizing Pore Opening while Blocking
- A hERG Blocker Facilitates K + Channel Current by Agonizing Pore Opening while Blocking
- Comment on "A MATLAB Algorithm to Automatically Estimate the QT Interval and Other ECG Parameters and Validation Using a Machine Learning Approach in Congenital Long-QT Syndrome"
- A hERG Blocker Facilitates K + Channel Current by Agonizing Pore Opening while Blocking
- A hERG Blocker Facilitates K+ Channel Current by Agonizing Pore Opening while Blocking